Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Vaccine|September 25, 2003
Safety and immunogenicity of a peptide containing the cross-neutralization epitope of HPV16 L2 administered nasally in healthy volunteersKei Kawana, Toshiharu Yasugi, Tadahito Kanda, et al.
The American Journal of Surgical Pathology|July 15, 2015
Myoepithelioma-like Tumors of the Vulvar Region: A Distinctive Group of SMARCB1-deficient NeoplasmsAkihiko Yoshida, Hiroshi Yoshida, Masayuki Yoshida, et al.
Cancer Science|July 15, 2010
Tobacco smoking and regression of low-grade cervical abnormalitiesKoji Matsumoto, Akinori Oki, Reiko Furuta, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|June 3, 2008
hScrib, a human homologue of Drosophila neoplastic tumor suppressor, is a novel death substrate targeted by caspase during the process of apoptosisKenbun Sone, Shunsuke Nakagawa, Keiichi Nakagawa, et al.
International Journal of Clinical Oncology|July 13, 2011
Subsequent risks for cervical precancer and cancer in women with low-grade squamous intraepithelial lesions unconfirmed by colposcopy-directed biopsy: results from a multicenter, prospective, cohort studyKoji Matsumoto, Yasuo Hirai, Reiko Furuta, et al.
Cancers|January 26, 2020
Multistate Markov Model to Predict the Prognosis of High-Risk Human Papillomavirus-Related Cervical LesionsAyumi Taguchi, Konan Hara, Jun Tomio, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2012
HLA class II DRB1*1302 allele protects against progression to cervical intraepithelial neoplasia grade 3: a multicenter prospective cohort studyKoji Matsumoto, Hiroo Maeda, Akinori Oki, et al.
Cancer Science|August 4, 2015
Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?Koji Matsumoto, Hiroo Maeda, Akinori Oki, et al.
International Journal of Clinical Oncology|October 26, 2012
Association between carotenoids and outcome of cervical intraepithelial neoplasia: a prospective cohort studyTakuma Fujii, Naoyoshi Takatsuka, Chisato Nagata, et al.
Journal of Medical Virology|May 16, 2012
Do neutralizing antibody responses generated by human papillomavirus infections favor a better outcome of low-grade cervical lesions?Hiroyuki Ochi, Koji Matsumoto, Kazunari Kondo, et al.
Pageof 8